Want to join the conversation?
Specialty pharmaceutical company $VRX said the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the US FDA has voted by 18 to 0 to brodalumab injection, 210 mg, for adult patients with moderate-to-severe plaque psoriasis. FDA will consider this recommendation in its review of the Biologics License Applications for brodalumab.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?